Suppressive and Pro-inflammatory Roles for IL-4 in the Pathogenesis of Experimental Drug-induced Liver Injury: a Review

Overview

Journal Expert Opin Drug Metab Toxicol

Publisher Informa Healthcare

Specialties Endocrinology
Pharmacology
Toxicology

Date 2010 Feb 20

PMID 20166853

Citations 13

Authors

Dolores B Njoku

Affiliations

Soon will be listed here.

Abstract

Importance Of The Field: Idiosyncratic drug reactions resulting in drug-induced liver injury (DILI) account for approximately 13% of acute liver failure cases in the US. Idiosyncratic drug reactions are the third most common cause of liver transplantation, exceeded only by acetaminophen and indeterminate causes. Clinical evidence suggests that idiosyncratic DILI is triggered by drug hapten-altered self proteins resulting in hepatocellular injury. An example of this type of DILI is hepatitis that develops in susceptible individuals following administration of halogenated volatile anesthetics, dihydralazine, carbamazepine or diclofenac.

Areas Covered In This Review: In this review, we describe research in animal models that supports a critical role for suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of immune-mediated DILI.

What The Reader Will Gain: The reader will gain insights into the roles of IL-4 in the development of experimental DILI. The reader will gain tools to assist in the translation of these findings to those in patients with immune-mediated DILI, as well as other inflammatory diseases of the liver. The reader will then be made aware of gaps in knowledge in the pathogenesis of DILI where research could result in significant advances in the care of these complicated patients.

Take Home Message: In experimental immune-mediated DILI, IL-4 suppresses regulatory responses to CYP2E1 autoantigens but induces pro-inflammatory responses to drug haptens.

Citing Articles

Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver.

Zhao Y, Li J, Liu Y, Zhu Y, Zhang Y, Zheng W World J Hepatol. 2025; 17(2):101741.

PMID: 40027577 PMC: 11866136. DOI: 10.4254/wjh.v17.i2.101741.

Anti-inflammatory effect and antihepatoma mechanism of carrimycin.

Li X, Luo Y, Wang Y, Yang Z, Shang Y, Guan Q World J Gastroenterol. 2023; 29(14):2134-2152.

PMID: 37122599 PMC: 10130968. DOI: 10.3748/wjg.v29.i14.2134.

Effects of Casein Phosphopeptide-Selenium Complex on the Immune Functions in Beagle Dogs.

Wang W, Xu L, Cao Y, Liu G, Lin Q, Mao X Animals (Basel). 2022; 12(16).

PMID: 36009627 PMC: 9404450. DOI: 10.3390/ani12162037.

Endometrial regenerative cells with galectin-9 high-expression attenuate experimental autoimmune hepatitis.

Wang H, Zhao Y, Ren B, Qin Y, Li G, Kong D Stem Cell Res Ther. 2021; 12(1):541.

PMID: 34654474 PMC: 8518235. DOI: 10.1186/s13287-021-02604-2.

Naringin and Hesperidin Counteract Diclofenac-Induced Hepatotoxicity in Male Wistar Rats Their Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities.

Hassan R, Hozayen W, Abo Sree H, Al-Muzafar H, Amin K, Ahmed O Oxid Med Cell Longev. 2021; 2021:9990091.

PMID: 34422219 PMC: 8376442. DOI: 10.1155/2021/9990091.

References

Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View

Neuberger J, Mieli-Vergani G, Tredger J, Davis M, Williams R . Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut. 1981; 22(8):669-72. PMC: 1420052. DOI: 10.1136/gut.22.8.669. View

Bourdi M, Eiras D, Holt M, Webster M, Reilly T, Welch K . Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury. Chem Res Toxicol. 2007; 20(2):208-16. DOI: 10.1021/tx060228l. View

Schiodt F, Atillasoy E, Shakil A, Schiff E, Caldwell C, Kowdley K . Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999; 5(1):29-34. DOI: 10.1002/lt.500050102. View

Moscat J, Rennert P, Diaz-Meco M . PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 2005; 13(5):702-11. DOI: 10.1038/sj.cdd.4401823. View

Gascan H, Gauchat J, Roncarolo M, Yssel H, Spits H, De Vries J . Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med. 1991; 173(3):747-50. PMC: 2118815. DOI: 10.1084/jem.173.3.747. View

Adkinson Jr N, Essayan D, Gruchalla R, Haggerty H, Kawabata T, Sandler J . Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol. 2002; 109(3):S461-78. DOI: 10.1067/mai.2002.122214. View

Pohl L, Kenna J, Satoh H, Christ D, Martin J . Neoantigens associated with halothane hepatitis. Drug Metab Rev. 1989; 20(2-4):203-17. DOI: 10.3109/03602538909103537. View

Vidali M, Occhino G, Ivaldi A, Serino R, Moia S, Alchera E . Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C. J Hepatol. 2007; 46(4):605-12. DOI: 10.1016/j.jhep.2006.11.009. View

10.

Svensson L, Nandakumar K, Johansson A, Jansson L, Holmdahl R . IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur J Immunol. 2002; 32(10):2944-53. DOI: 10.1002/1521-4141(2002010)32:10<2944::AID-IMMU2944>3.0.CO;2-4. View

11.

Pohl L, Thomassen D, Pumford N, Butler L, Satoh H, Ferrans V . Hapten carrier conjugates associated with halothane hepatitis. Adv Exp Med Biol. 1991; 283:111-20. DOI: 10.1007/978-1-4684-5877-0_12. View

12.

Nakai K, Tanaka H, Hanada K, Ogata H, Suzuki F, Kumada H . Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in.... Drug Metab Dispos. 2008; 36(9):1786-93. DOI: 10.1124/dmd.107.020073. View

13.

Caturegli P, Kuppers R, Mariotti S, Burek C, Pinchera A, Ladenson P . IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol. 1994; 98(3):464-9. PMC: 1534515. DOI: 10.1111/j.1365-2249.1994.tb05514.x. View

14.

Williams B, White N, Amlot P, Slaney J, Toseland P . Circulating immune complexes after repeated halothane anaesthesia. Br Med J. 1977; 2(6080):159-62. PMC: 1631097. DOI: 10.1136/bmj.2.6080.159. View

15.

McDevitt H, Unanue E . Autoimmune diabetes mellitus--much progress, but many challenges. Adv Immunol. 2008; 100:1-12. DOI: 10.1016/S0065-2776(08)00801-8. View

16.

Iannello A, Samarani S, Debbeche O, Tremblay C, Toma E, Boulassel M . Role of interleukin-18 in the development and pathogenesis of AIDS. AIDS Rev. 2009; 11(3):115-25. View

17.

Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C . Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med. 2002; 196(1):77-85. PMC: 2194010. DOI: 10.1084/jem.20020439. View

18.

Aithal G, Ramsay L, Daly A, Sonchit N, Leathart J, Alexander G . Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology. 2004; 39(5):1430-40. DOI: 10.1002/hep.20205. View

19.

Turley S, Poirot L, Hattori M, Benoist C, Mathis D . Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med. 2003; 198(10):1527-37. PMC: 2194112. DOI: 10.1084/jem.20030966. View

20.

Njoku D, Laster M, Gong D, Eger 2nd E, Reed G, Martin J . Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg. 1997; 84(1):173-8. DOI: 10.1097/00000539-199701000-00031. View